1859
1859.ai
Machine Learning
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$49.7M
4 rounds on record
Latest round
$40M
Venture round · Nov 2021 · 4 yr ago
Team
51-200
employees, estimated range
The money's age
Long since its last round
59 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 17, 2021
Raised a round Venture round $40M · SEC Form D
Sep 28, 2021
Took on debt financing $2M · SEC Form D
Aug 11, 2020
Raised a round Venture round $9.7M · SEC Form D
Jun 26, 2019
Took on debt financing $500k · SEC Form D
2019
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2021 | $40M | — | SEC Form D |
| Debt Financing | Sep 2021 | $2M | — | SEC Form D |
| Venture round | Aug 2020 | $9.7M | — | SEC Form D |
| Debt Financing | Jun 2019 | $500k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | 1859, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Devon CayerExecutive Officer, DirectorSEC Form D
Andrew MacConnellExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate…
Lantern uses cutting-edge machine learning to guide what, when, and how distributors buy.
Generating a chemical atlas for treating human disease. Our ATLAS technology merges AcTive® Learning with Automated Synthesis and…
By using reality capture, game engine tech and machine learning Twinverse provides 3D solutions for operations and maintenance.
Chemify builds a programmable chemistry platform that turns digital molecule designs into synthesis. Its chemputer robots execute code…
Open source machine learning dev environments. Click the link, try it out.
Overview
1859 integrates combinatorial chemistry, pico-scale activity-based screening and machine learning to generate millions of empirical datapoints every week and discover novel small molecule therapeutics.
People
Devon Cayer
Executive Officer, Director
Andrew MacConnell
Executive Officer, Director
John Drewry
Director
Paul Conley
Director
Dan Faro
Director
Lily Li
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego
United States
HQ
50-200 est. staff